NIEDDU, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 671
EU - Europa 374
AS - Asia 231
OC - Oceania 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.286
Nazione #
US - Stati Uniti d'America 669
CN - Cina 128
UA - Ucraina 124
IT - Italia 113
SG - Singapore 74
DE - Germania 50
FR - Francia 35
FI - Finlandia 21
TR - Turchia 17
BE - Belgio 8
GB - Regno Unito 7
AU - Australia 4
GR - Grecia 4
KR - Corea 3
SE - Svezia 3
BR - Brasile 2
CA - Canada 2
EU - Europa 2
HR - Croazia 2
IN - India 2
JP - Giappone 2
ES - Italia 1
IM - Isola di Man 1
LU - Lussemburgo 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 1.286
Città #
Chandler 203
Jacksonville 79
Singapore 64
New York 57
Princeton 52
Sassari 51
Nanjing 30
Ann Arbor 29
Dearborn 24
Wilmington 22
Izmir 14
Beijing 13
Changsha 12
Nanchang 11
Santa Clara 11
Brussels 8
Shenyang 7
Tianjin 7
Villiers-sur-marne 7
Boardman 6
Hebei 6
Mountain View 6
Ashburn 5
Cagliari 5
Hangzhou 5
Woodbridge 5
Helsinki 4
Jiaxing 4
Ningbo 4
Pátrai 4
Shanghai 4
Zhengzhou 4
Dallas 3
Melbourne 3
Oristano 3
San Francisco 3
Seoul 3
Auburn Hills 2
Fairfield 2
Kunming 2
Norwalk 2
Porto Torres 2
Romola 2
Serramanna 2
Shenzhen 2
Taizhou 2
Toronto 2
Zagreb 2
Adelaide 1
Amsterdam 1
Andover 1
Bangkok 1
Bratislava 1
Cedar Knolls 1
Changchun 1
Chernihiv 1
Città Di Castello 1
Cupertino 1
Denver 1
Douglas 1
Fuzhou 1
Hanoi 1
Hanover 1
Harrow 1
Jinan 1
Jinhua 1
Kathmandu 1
Lanzhou 1
Leipzig 1
Lima 1
London 1
Los Angeles 1
Luxembourg 1
Munich 1
New Plymouth 1
Oslo 1
Potenza 1
Quezon 1
Rome 1
San Jose 1
Seattle 1
Secaucus 1
Sinnai 1
São Paulo 1
Tappahannock 1
Tokyo 1
Warsaw 1
Wuxi 1
Xi'an 1
Totale 841
Nome #
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 75
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 66
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 64
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 61
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 60
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 56
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 54
Identification and characterization of biomarkers in atherosclerosis and diabetes. 53
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 49
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 47
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 45
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 42
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 41
Collagenic architecture and morphotraits in a marine basal metazoan as a model for bioinspired applied research 41
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 40
Urine bikunin as a marker of renal impairment in Fabry's disease 40
Identification and characterization of biomarkers in atherosclerosis and diabetes 31
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 31
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 29
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 27
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 27
Morphological and biochemical traits of target marine sponges 26
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 23
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 21
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 20
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 18
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 17
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 13
Molecular and pathobiological insights of bikunin/UTI in cancer 12
Totale 1.321
Categoria #
all - tutte 7.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020133 0 0 0 0 23 22 27 2 21 15 23 0
2020/2021151 22 1 23 3 22 1 22 2 29 25 1 0
2021/2022165 16 1 2 7 5 0 4 6 35 12 21 56
2022/2023341 29 40 8 53 44 45 0 51 43 5 18 5
2023/2024167 13 11 1 5 35 42 1 10 9 11 14 15
2024/2025120 1 7 64 23 25 0 0 0 0 0 0 0
Totale 1.321